New hope for ovarian cancer: drug combo targets resistant tumors
NCT ID NCT05551507
First seen May 15, 2026 · Last updated May 19, 2026 · Updated 1 time
Summary
This study tests a new drug called IN10018 combined with standard chemotherapy for people with a tough-to-treat type of ovarian cancer that no longer responds to platinum-based treatments. About 150 adults will join to see if the combo is safe and shrinks tumors. The goal is to find a better way to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLATINUM-RESISTANT OVARIAN CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Obstetrics and Gynecology Hospital of Zhejiang University
RECRUITINGHangzhou, China
Contact
-
Anyang Cancer Hospital
RECRUITINGAnyang, China
Contact
-
Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College
RECRUITINGBeijing, China
Contact
-
Fujian Cancer Hospital
RECRUITINGFuzhou, China
Contact
-
Henan Cancer Hospital
RECRUITINGZhengzhou, China
Contact
-
Hunan Cancer Hospital
RECRUITINGChangsha, China
Contact
-
Tianjin Cancer Hospital
RECRUITINGTianjin, China
Contact
Conditions
Explore the condition pages connected to this study.